Další formáty:
BibTeX
LaTeX
RIS
@proceedings{920561, author = {Řiháček, Ivan and Fráňa, Petr and Schwarz, Daniel and Plachý, Martin and Souček, Miroslav}, booktitle = {The 23rd Scientific Meeting of The International Society of Hypertension, Vancouver, 26-30.9.2010}, keywords = {hypertensio; 24 hour ambulatory blood pressure monitoring; telmisartane; losartane; metabolic parameters}, language = {eng}, title = {Losartane and Telmisartane in the Patients with Newly Diagnosed Hypertension and Metabolic Syndrome Effect of One Year of Treatment to Clinical Blood Pressure, 24h Blood Pressure, Metabolic and Anthropometric Parameters.}, year = {2010} }
TY - CONF ID - 920561 AU - Řiháček, Ivan - Fráňa, Petr - Schwarz, Daniel - Plachý, Martin - Souček, Miroslav PY - 2010 TI - Losartane and Telmisartane in the Patients with Newly Diagnosed Hypertension and Metabolic Syndrome Effect of One Year of Treatment to Clinical Blood Pressure, 24h Blood Pressure, Metabolic and Anthropometric Parameters. KW - hypertensio KW - 24 hour ambulatory blood pressure monitoring KW - telmisartane KW - losartane KW - metabolic parameters N2 - Objective: To determine the clinical, 24h blood pressure metabolic and anthropometric effects of once daily dosed sartans. Methods: 57 patients in two groups before and after 1 year of treatment with losartane or telmisartane once daily. Results: smoothness index of losartane plus minus standard error of mean was 1,10 plus minus 0,13 for SBPP, 0,81 plus minus 0,11 for DBP, RDH index of losartane was (24,24,0) for both BP. Smoothness index of telmisartane was 1,00 plus minus 0,11 for SBP, 0,84 plus minus 0,10 for DBP, RDH index of telmisartane was (24,24,0) for SBP and (22,15,1) for DBP. No statistically significant changes heart rate, metabolic and anthropometric parameters. Conclusion: losartane have reasonably better homogenous effect on diastolic BP throughout 24h than telmisartane. There are no changes in metabolic parameters. ER -
ŘIHÁČEK, Ivan, Petr FRÁŇA, Daniel SCHWARZ, Martin PLACHÝ a Miroslav SOUČEK. Losartane and Telmisartane in the Patients with Newly Diagnosed Hypertension and Metabolic Syndrome Effect of One Year of Treatment to Clinical Blood Pressure, 24h Blood Pressure, Metabolic and Anthropometric Parameters. In \textit{The 23rd Scientific Meeting of The International Society of Hypertension, Vancouver, 26-30.9.2010}. 2010. ISSN~0263-6352.
|